The transparency of published health technology assessment-based recommendations on pharmaceutical reimbursement in Poland

被引:7
|
作者
Bochenek, Tomasz [1 ]
Kocot, Ewa [2 ]
Rodzinka, Marcin [3 ]
Godman, Brian [4 ,5 ]
Maciejewska, Katarzyna [3 ]
Kamal, Susan [6 ]
Pilc, Andrzej [7 ]
机构
[1] Jagiellonian Univ, Dept Drug Management, Fac Hlth Sci, Coll Med, PL-31531 Krakow, Poland
[2] Jagiellonian Univ, Hlth Econ & Social Secur Dept, Fac Hlth Sci, Coll Med, Krakow, Poland
[3] Jagiellonian Univ, Hlth Promot Dept, Fac Hlth Sci, Coll Med, Krakow, Poland
[4] Karolinska Inst, Div Clin Pharmacol, Stockholm, Sweden
[5] Strathclyde Univ, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland
[6] Univ Lausanne, Univ Geneva, Sch Pharmaceut Sci, Community Pharm Dept, Geneva, Switzerland
[7] Polish Acad Sci, Inst Pharmacol, Dept Neurobiol, Krakow, Poland
关键词
Health technology assessment; HTA; pharmaceutical reimbursement; public information; citizens' rights; transparency; Poland; RISK-SHARING ARRANGEMENTS; INVOLVEMENT; MEDICINES;
D O I
10.1080/14737167.2017.1262767
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: The appropriate access to public information is very important for healthcare system stakeholders. The goal of this study was to examine how the execution of the formally existing right to public information on the HTA-based recommendations on reimbursement of new health technologies from public funds has been changing in Poland.Methods: All recommendations published within two predefined equal periods of time between 2013 and 2015 were analyzed. The gathered data was subjected to statistical analysis.Results: The frequency and intensity of censoring the published HTA-based recommendations on the pharmaceutical reimbursement has diminished. The text readability and clarity of message has improved, although the degree of decisiveness of the recommendations has dropped.Conclusion: The positive changes in the public communication policy should be continued. The transparency of the HTA-based recommendations should be increased further in some areas in the future.
引用
收藏
页码:385 / 400
页数:16
相关论文
共 50 条
  • [1] Reimbursement of biosimilars in Poland: is there a link to health technology assessment?
    Neumann, Dominika
    Jablecka, Anna
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2016, 16 (06) : 781 - 792
  • [2] IMPLEMENTING HEALTH TECHNOLOGY ASSESSMENT-BASED RECOMMENDATIONS IN FINLAND: MANAGED UPTAKE OF MEDICAL METHODS
    Sihvo, Sinikka
    Ikonen, Tuija
    Makela, Marjukka
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2017, 33 (04) : 430 - 433
  • [3] Relating Health Technology Assessment recommendations and reimbursement decisions in Poland in years 2012-2014, a retrospective analysis
    Kawalec, Pawel
    Malinowski, Krzysztof Piotr
    HEALTH POLICY, 2016, 120 (11) : 1240 - 1248
  • [4] The role of health technology assessment on pharmaceutical reimbursement in selected middle-income countries
    Oortwijn, Wija
    Mathijssen, Judith
    Banta, David
    HEALTH POLICY, 2010, 95 (2-3) : 174 - 184
  • [5] PHARMACEUTICAL SYSTEM IN UKRAINE: IMPLEMENTATION OF EXTERNAL REFERENCE PRICING, REIMBURSEMENT PROGRAMS AND HEALTH TECHNOLOGY ASSESSMENT
    Piniazhko, O.
    Zaliska, O.
    Ilyk, R.
    Stasiv, Kh-O
    PHARMACIA, 2018, 65 (02) : 28 - 39
  • [6] A DECADE OF HEALTH TECHNOLOGY ASSESSMENT IN POLAND
    Lipska, Iga
    McAuslane, Neil
    Leufkens, Hubert
    Hovels, Anke
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2017, 33 (03) : 350 - 357
  • [7] The politics of health technology assessment in Poland
    Ozieranski, Piotr
    McKee, Martin
    King, Lawrence
    HEALTH POLICY, 2012, 108 (2-3) : 178 - 193
  • [8] Health technology assessment in Poland, the Czech Republic, Hungary, Romania and Bulgaria
    Gulacsi, Laszlo
    Rotar, Alexandru M.
    Niewada, Maciej
    Loeblova, Olga
    Rencz, Fanni
    Petrova, Guenka
    Boncz, Imre
    Klazinga, Niek S.
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2014, 15 : S13 - S25
  • [9] Health technology assessment-based development of a Spanish breast cancer patient decision aid
    Izquierdo, Fatima
    Gracia, Javier
    Guerra, Mercedes
    Antonio Blasco, Juan
    Andradas, Elena
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2011, 27 (04) : 363 - 368
  • [10] Health Technology Assessment Process for Oncology Drugs: Impact of CADTH Changes on Public Payer Reimbursement Recommendations
    Binder, Louise
    Ghadban, Majd
    Sit, Christina
    Barnard, Kathleen
    CURRENT ONCOLOGY, 2022, 29 (03) : 1514 - 1526